The company told CBS it will charge around $80 for a 30-day supply of Vuity, a once-daily eyedrop formulation of muscarinic cholinergic agonist pilocarpine intended as an alternative to reading ...
The approval has been granted to Vuity (formerly AGN-190584), a once-daily eyedrop formulation of muscarinic cholinergic agonist pilocarpine developed by AbbVie's Allergen unit that is now an ...
This is an important study using a combination of optogenetics and calcium imaging to provide insight into the function of the cholinergic input to the prelimbic cortex in probabilistic spatial ...
The US Food and Drug Administration approved (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults in September, making it is the first antipsychotic ...
A variety of antidotes have been reported to treat SSRI-induced sexual dysfunction effectively; however, virtually all the data on these agents are derived from open case reports and case series ...
Pemphigus is a rare autoimmune blistering disease involving the skin and mucous epithelia. It is clinically characterized by flaccid blisters and erosions (Figure 1) and, if left untreated, could ...
And while Musk’s body is in the spotlight now, it’s not the first time he’s admitted to using GLP-1 agonists to manage his weight. In October 2022, he was asked on X what his “secret” to ...
These receive incoming impulses from other neurones. Information from receptors passes along neurones, as electrical impulses to co-ordinators such as the central nervous system or CNS.